Royal Bank of Canada’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-698
| Closed | -$38K | – | 7675 |
|
|
2022
Q2 | $38K | Sell |
698
-917
| -57% | -$49.9K | ﹤0.01% | 5381 |
|
|
2022
Q1 | $52K | Sell |
1,615
-1,125
| -41% | -$36.2K | ﹤0.01% | 5588 |
|
|
2021
Q4 | $59K | Buy |
2,740
+612
| +29% | +$13.2K | ﹤0.01% | 5753 |
|
|
2021
Q3 | $47K | Hold |
2,128
| – | – | ﹤0.01% | 5694 |
|
|
2021
Q2 | $41K | Hold |
2,128
| – | – | ﹤0.01% | 5681 |
|
|
2021
Q1 | $37K | Hold |
2,128
| – | – | ﹤0.01% | 5580 |
|
|
2020
Q4 | $34K | Hold |
2,128
| – | – | ﹤0.01% | 5280 |
|
|
2020
Q3 | $23K | Sell |
2,128
-17,456
| -89% | -$189K | ﹤0.01% | 5164 |
|
|
2020
Q2 | $237K | Sell |
19,584
-4,382
| -18% | -$53K | ﹤0.01% | 3886 |
|
|
2020
Q1 | $235K | Buy |
23,966
+5,300
| +28% | +$52K | ﹤0.01% | 3750 |
|
|
2019
Q4 | $256K | Buy |
18,666
+18,588
| +23,831% | +$255K | ﹤0.01% | 3892 |
|
|
2019
Q3 | $1K | Buy |
78
+75
| +2,500% | +$962 | ﹤0.01% | 5895 |
|
|
2019
Q2 | $0 | Sell |
3
-25
| -89% | – | ﹤0.01% | 6118 |
|
|
2019
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 5553 |
|
|
2018
Q4 | $1K | Hold |
28
| – | – | ﹤0.01% | 5714 |
|
|
2018
Q3 | $2K | Hold |
28
| – | – | ﹤0.01% | 5938 |
|
|
2018
Q2 | $3K | Hold |
28
| – | – | ﹤0.01% | 5621 |
|
|
2018
Q1 | $2K | Hold |
28
| – | – | ﹤0.01% | 5533 |
|
|
2017
Q4 | $4K | Sell |
28
-6
| -18% | -$857 | ﹤0.01% | 5397 |
|
|
2017
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 5813 |
|
|
2017
Q2 | $1K | Hold |
34
| – | – | ﹤0.01% | 5708 |
|
|
2017
Q1 | $2K | Hold |
34
| – | – | ﹤0.01% | 5765 |
|
|
2016
Q4 | $2K | Hold |
34
| – | – | ﹤0.01% | 5727 |
|
|
2016
Q3 | $2K | Hold |
34
| – | – | ﹤0.01% | 5446 |
|
|
2016
Q2 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 5453 |
|